|
 |
|||||||
 |
DEVELOPMENT PARTNERS Synteract, Inc. Established in 1995 Synteract is a privately-held, full service contract research organization (CRO), dedicated to meeting the various needs of biotechnology, biomedical, pharmaceutical and drug industry firms. Synteract is working as the CRO for CoFactor in the U.S. Synteract has comprehensive capabilities, from protocol development and site management to data collection, electronic submissions, and safety surveillance. Based in Carlsbad, California, with a branch office in Pennsylvania, Synteract provides expertise in a wide range of therapeutic areas and maintains a wealth of knowledge in oncology, ophthalmology, HIV, erectile dysfunction, cardiovascular disease, and pain. Since 2000, it has been a key development shop for web, wireless and voice data solutions that speed the completion of clinical trials and assist in access to clinical trials information. This includes technologies such as electronic data capture (EDC), interactive voice response systems (IVRS) and automated safety tracking and reporting. To learn more about Synteract, visit www.synteract.com. Pharm-Olam International Pharm-Olam International (POI) is a multi-national contract research organization, with global headquarters in Houston, TX. Pharm-Olam offers a wide range of comprehensive clinical trial management services to the pharmaceutical, biotechnology and medical device industries. Pharm-Olam is focused on delivering high-quality data, achieving targeted enrollment, and meeting projected timelines all within a very competitive budget. Pharm-Olam International works as the CRO for the Company's CoFactor trials outside the US. To learn more about POI, visit www.pharm-olam.com. |
